17/10/2025
U Proton Medu verujemo da je zdravstvo mnogo više od medicine, to je pokretač promena, jednakosti i napretka.
Naš osnivač i direktor kompanije HealthWatch Swiss AG, Themis Moustakas, podseća da budućnost medicine ne zavisi samo od tehnologije i laboratorija, već od povezivanja znanja, dostupnosti i humanosti.
Kompanija HealthWatch Swiss AG (HWS), kao matična kompanija Proton Meda, predvodi misiju grupe da unapredi medicinske inovacije i obezbedi bezbednija, pametnija i pristupačnija zdravstvena rešenja.
Na konferenciji Hellenic Impact Investing Conference (HIIC25) Themis se pridružio liderima iz oblasti zdravstva i biomedicinskih nauka u razgovoru o tome kako saradnja i inovacije mogu oblikovati zdraviju i inkluzivniju budućnost.
Za nas, inovacija bez dostupnosti nije napredak. Prava promena znači omogućiti terapije koje dopiru do što većeg broja ljudi i doprinose kvalitetnijem životu.
Pridružite nam se na ovom putu. Zajedno možemo stvoriti svet u kojem briga, nauka i saosećanje napreduju ruku pod ruku.
At Proton Med, we see healthcare as more than medicine, it’s a force for impact, equity, and transformation.
Our founder and CEO of HealthWatch Swiss AG, Themis Moustakas, reminds us that the future of medicine lies not just in technology or labs, but in connecting expertise, access, and humanity.
HealthWatch Swiss AG (HWS), the parent company of Proton Med, leads our group’s mission to advance medical innovation and ensure safer, smarter, and more accessible healthcare solutions.
At the Hellenic Impact Investing Conference (HIIC25), Themis joined leaders from the healthcare and life sciences industries to discuss how collaboration and innovation can shape a healthier, more inclusive future.
For us, innovation without accessibility is not progress. Real change means enabling therapies that reach more people and improve lives.
Join us on this journey. Together, we can create a world where care, science, and compassion move forward hand in hand.